Popular Articles

Trubion Announces Positive Data From A Phase 1 / 2 Study Of TRU-016 For The Treatment Of Chronic Lymphocytic Leukemia (CLL)
Trubion Pharmaceuticals, Inc. (Nasdaq: TRBN) announced the presentation of encouraging Phase 1 safety and efficacy results following administration of low doses of TRU-016 in heavily pre-treated patients with high-risk genomic factors and relapsed or refractory chronic lymphocytic leukemia (CLL). TRU-016 is the Company"s proprietary anti-CD37 Small Modular ImmunoPharmaceutical (SMIP(TM)) product candidate.

Fungal Toxin Mystery Solved Using Biolog's Phenotype MicroArrayTM Technology
An important breakthrough in fungal toxin biology has been made possible through the use of Biolog"s Phenotype MicroArray technology. This major advance is described in two recent publications from a group at CSIRO in Queensland, Australia. The work by Donald Gardiner and his collaborators has recently been published in online editions of the journals Fungal Genetics and Biology and Microbiology.
News of the day
Health Affairs Study Finds No Link Between Cost, Quality Of Care
Quality of care is not linked to the cost of care, according to a study published last week on the Web site of the journal Health Affairs, CQ HealthBeat reports. For the study, researchers from Dartmouth College and Harvard University analyzed the health care bills of chronically ill Medicare beneficiaries in their last two years of life who received end-of-life care from 2,172 unidentified hospitals. The patients had one of three common conditions: heart attack, pneumonia or congestive heart failure. The study -- sponsored by the National Institute on Aging -- looked at common quality indicators at a hospital-by-hospital level instead of regional level (Norman, CQ HealthBeat, 5/22). Researchers compared the data with some of the quality measures reported on the HHS Hospital Compare Web site (Goldstein, "Health Blog," Wall Street Journal, 5/21). The study found that among the one-fifth of hospitals that spent the least, the cost of end-of-life care was $16,059 on average. In comparison, the cost of end-of-life care at the top 20% of highest-spending hospitals was $34,742 on average. The study also found no link -- or even evidence against a link -- between spending and the quality indicators. The researchers noted that the results might be skewed because the quality indicators they used might penalize hospitals that treat sicker patients. In addition, the study used process-of-care measures instead of patient outcomes. According to CQ HealthBeat, the findings of the study could have an effect on the debate over health care reform legislation because lawmakers and President Obama both have said that a reform plan must be able to control costs and expand access to high-quality, affordable health care (CQ HealthBeat, 5/22).
Endocrinology

Processing In The Brain's Reward Pathways May Be Affected By Childhood Adversity

New research shows that childhood adversity is associated with diminished neural activity in brain regions implicated in the anticipation of possible rewards. Scientists at Harvard University used functional magnetic resonance imaging (fMRI) to monitor brain activity as participants played a game involving cues that predicted monetary rewards and penalties. "We found that, in comparison to community controls, young adults who had experienced childhood adversity showed weaker responses to reward-predicting cues in left hemisphere regions of the basal ganglia, a part of the brain that is important for orchestrating goal-directed actions," says Diego Pizzagalli, the John and Ruth Hazel Associate Professor of the Social Sciences in the Department of Psychology at Harvard. The research is published in the current issue of the journal Biological Psychiatry, and was conducted by Pizzagalli and Karlen Lyons-Ruth, associate professor of psychology at Harvard Medical School. The lead author is Daniel Dillon, a postdoctoral researcher working with Pizzagalli, and co-authors were Avram Holmes, Jeffrey Birk, and Nancy Brooks, all in the Department of Psychology in Harvard"s Faculty of Arts and Sciences. "In the group that had childhood adversity, two structures in the left basal ganglia were not responsive to reward cues, which differed from what we saw in the control group," says Dillon. "There weren"t any differences between the controls and maltreated participants in response to cues that predicted either penalties or no incentive outcomes. In other words, the group that had experienced childhood adversity only showed a weaker response to the reward cues." Participants also rated their experiences of positive and negative arousal in response to the cues while in the MRI scanner. Relative to controls, the participants who had experienced childhood adversity rated the reward cues as less positive, consistent with the weaker brain response to these cues. Most of the study participants did not currently meet criteria for any psychological disorder, but childhood adversity, such as emotional, physical, or sexual maltreatment, is known to increase the risk for psychopathology, particularly depression. Many previous studies have suggested that the link between childhood adversity and depression might be related to dysfunction in brain regions that are involved in regulating stress, which would contribute to the excessive sadness and negativity that characterizes depression. By contrast, according to the researchers, this study highlights another potential link: by weakening the brain"s response to rewards, childhood adversity may contribute to other important symptoms of depression, such as apathy, low motivation, and a reduced ability to experience pleasure. By identifying specific regions of the brain impacted in certain types of psychological disorders, the researchers hope to contribute to the development of more effective treatments for these disorders. "Eventually, we hope that this type of research will help fine-tune these interventions in much more personalized and hopefully effective ways," says Pizzagalli. The 13 maltreated individuals who participated in the study were young adults who had been followed since childhood as part of a study from the Cambridge Health Alliance, led by Lyons-Ruth. The participants had experienced childhood abuse that met state guidelines for maltreatment, but most were not currently experiencing any symptoms of depression, posttraumatic stress, or other disorders. Pizzagalli underlined the fact that while childhood adversity increases the risk for depression, it is not a one-to-one relationship: Other mitigating factors, such as genetics and social support, can counteract the risk. "This is a serious problem, and we are just starting to grasp what the potential neurobiological consequences will be," says Pizzagalli. "It"s not a direct pathway: Somebody who was exposed to early adversity will not necessarily develop depression. But an important first step to improving treatment is to try to understand what the changes in the brain might be, so that we can know how and when to intervene." The research was funded by the National Institute of Mental Health, the Robert Wood Johnson Foundation, the Society Scholars program and the Talley Fund. Amy Lavoie Harvard University


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):